Skip to main content
. 2014 Apr 9;18(3):260–265. doi: 10.1055/s-0034-1373782

Table 1. Demographic and clinical findings in head and neck non-Hodgkin lymphomas in patients with HIV (n = 24).

Patient no. Gender Age (y) Risk factor Neoplasm stage Bone marrow infiltration LDH level
1 M 52 UHC Ie Negative 1,422
2 M 31 Hemophilic Ie Negative N/D
3 M 44 IVDA IVe N/D N/D
4 M 26 IVDA IIe N/D 843
5 M 32 IVDA IIe N/D 950
6 M 38 IVDA IIe Negative 1,375
7 M 43 IVDA IVe Positive N/D
8 M 51 NPHC IIe Negative N/D
9 M 37 UHC IVes Positive 1,265
10 M 51 IVDA Ie Negative 1,433
11 F 25 UHC IIe Negative 1,186
12 F 24 UHC IIe Negative 489
13 M 35 UHC Ie Negative 313
14 M 38 IVDA IVe N/D 1,404
15 M 47 NPHC IVe Positive 2,721
16 M 39 IVDA IVe Positive 1,365
17 M 43 UHC Ie N/D 460
18 F 35 UHC Ie N/D 5,800
19 M 29 NPHC IIe N/D 468
20 M 37 UHC IIe N/D 926
21 F 60 UHC IIe N/D N/D
22 F 42 IVDA IVe N/D 2,988
23 M 39 IVDA Ie Negative 341
24 F 55 UHC Ie Negative 419

Abbreviations: HIV, human deficiency virus; IVDA, intravenous drug abuser; LDH, lactate dehydrogenase; N/D, not determined; NPHC, nonprotected homosexual contact; UHC, unprotected heterosexual contact.